Topics

PubMed Journals Articles About "Transjugular Approach Safe Effective Alternative Performing Portal Vein" RSS

07:46 EST 15th December 2019 | BioPortfolio

Transjugular Approach Safe Effective Alternative Performing Portal Vein PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Transjugular Approach Safe Effective Alternative Performing Portal Vein articles that have been published worldwide.

More Information about "Transjugular Approach Safe Effective Alternative Performing Portal Vein" on BioPortfolio

We have published hundreds of Transjugular Approach Safe Effective Alternative Performing Portal Vein news stories on BioPortfolio along with dozens of Transjugular Approach Safe Effective Alternative Performing Portal Vein Clinical Trials and PubMed Articles about Transjugular Approach Safe Effective Alternative Performing Portal Vein for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Transjugular Approach Safe Effective Alternative Performing Portal Vein Companies in our database. You can also find out about relevant Transjugular Approach Safe Effective Alternative Performing Portal Vein Drugs and Medications on this site too.

Showing "transjugular approach safe effective alternative performing portal vein" PubMed Articles 1–25 of 28,000+

The transjugular approach is a safe and effective alternative for performing portal vein embolization.

To evaluate the safety and efficacy of the novel technique, transjugular portal vein embolization (TPVE).A single-center retrospective review of 18 patients (12 males and 6 females; mean age, 62 years) who underwent TPVE between January 2012 and January 2013 was conducted. The technical success rate, future liver remnant (FLR) volume, total liver volume (TLV) and FLR/TLV ratio after PVE were analyzed. Liver function, including total bilirubin (TB), aspartate aminotransferase (AST), alanine aminotransferase ...


Dilatation of left portal vein after right portal vein embolization: a simple estimation for growth of future liver remnant.

To evaluate correlation between growth rate of left portal vein (LPV) and future liver remnant (FLR) after right portal vein embolization (PVE), and to design models predicting FLR growth rate and volume using LPV area measurements on CT.

Predicting Heart Failure After TIPS: Still More Questions Than Answers.

The transjugular intrahepatic portosystemic shunt (TIPS) is a percutaneous imaging-guided procedure that effectively reduces portal pressure by diverting blood from the portal to the systemic circulation. Despite being a very effective treatment for portal hypertension-related complications, the use of TIPS was hampered for many years by the high rate of TIPS dysfunction, an issue that has become almost anecdotal since the introduction of covered stents. (1)(1) Currently, development of post-TIPS hepatic en...


Application study of ultrasound-guided percutaneous portal vein punctures combined with bi-directionalangiography in the treatment by TIPS.

To investigate the safety, feasibility, and preliminary clinical experience of ultrasonic guided percutaneous portal vein punctures combined bi-directional angiography in the treatment by transjugular intrahepatic portosystemic shunt(TIPS). From January 2016 to June 2018, 15 patients with TIPS from our hospital who were treated by ultrasonic guided percutaneous portal vein punctures combined with bi-directional angiography were enrolled,and were recruited as experimental group. During the same period, 30 p...

Noncirrhotic Portal Hypertension: Current and Emerging Perspectives.

Idiopathic portal hypertension (IPH) and extrahepatic portal venous obstruction (EHPVO) are prototype noncirrhotic causes of portal hypertension (PHT), characterized by normal hepatic venous pressure gradient, variceal bleeds, and moderate to massive splenomegaly with preserved liver synthetic functions. Infections, toxins, and immunologic, prothrombotic and genetic disorders are possible causes in IPH, whereas prothrombotic and local factors around the portal vein lead to EHPVO. Growth failure, portal bili...

Portal Hypertension: Pathogenesis and Diagnosis.

Portal hypertension (PH) is an increase in the pressure gradient between portal vein and inferior vena cava. Increased resistance occurs at different levels within the portal venous system, followed by increased portal venous inflow. PH is the main driver of cirrhosis decompensation. Varices on endoscopy or portosystemic collaterals on imaging indicate PH. Although its cause is determined mostly via noninvasive tests, the gold standard to measure portal pressure in cirrhosis and determine its severity is he...

Portal Hypertensive Biliopathy in Adult Patients: Findings and Interventional Radiologic Treatment-A Single-Center Experience.

The aim of this study was to evaluate the morphologic appearance, the clinical scenario, and the outcomes of patients with portal hypertensive biliopathy (PHB), particularly in the symptomatic subgroup treated with interventional radiology (IR) procedures. The outcome of 20 patients with PHB were retrospectively reviewed over a 5-year period. In all cases, the extrahepatic portal vein occlusion (EHPVO) and the compensatory cavernomatosis was the cause of PHB. Eight out of 20 patients had severe symptoms (ja...

Systemic inflammation and portal vein thrombosis in cirrhotic patients with gastroesophageal varices.

Cirrhotic patients with gastroesophageal varices and non-tumoral portal vein thrombosis have a higher risk of re-bleeding and poor prognosis. This study aimed to analyze inflammatory biomarkers and thromboelastography in cirrhotic patients with portal vein thrombosis.

Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer: A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

The aim of this study was to evaluate how often left-sided portal hypertension (LPH) develops and how LPH affects the long-term outcomes of patients with pancreatic cancer treated with pancreaticoduodenectomy (PD) and resection of the portal vein (PV)/superior mesenteric vein (SMV) confluence.

Cephalic vein approach for the implantable central venous access: A retrospective review of the single institution's experiences; Cohort Study.

Long-term venous access is usually required in patients receiving chemotherapy. We hypothesized that, out of the various central line approach techniques, the cephalic vein cut-down technique can be a safe and simple alternative in terms of surgical safety, feasibility, cost-effectiveness, and functional outcomes.We retrospectively reviewed the medical records of 569 patients who underwent implantable central venous access between January 2012 and December 2014 at our hospital.We classified our cohort accor...

Clinico-epidemiological Profile of Extra Hepatic Portal Vein Obstruction: A Tertiary Care Hospital Based Retrospective Study.

Background Extra hepatic portal vein obstruction (EHPVO) is a common cause of portal hypertension in the developing countries (up to 30% of all variceal bleeders) and is second to cirrhosis in the West (up to 5-10%). Our understanding of the disease is poor compared with other illnesses. Objective To undertake a retrospective study of the clinicoepidemiological profile of Extra hepatic portal vein obstruction in a tertiary care hospital in eastern Nepal. Method All consecutive adult patients whose features ...

Management of Portal Hypertension and Ascites in Polycystic Liver Disease.

Patients suffering from polycystic liver disease may develop Hepatic Venous Outflow Obstruction, Portal Vein Obstruction and/or Inferior Caval Vein Syndrome due to cystic mass effect. This can cause portal hypertension, leading to ascites, variceal hemorrhage or splenomegaly. For this review, we evaluate the evidence to provide clinical guidance for physicians faced with this complication. Diagnosis is made with imaging such as ultrasound, CT or MRI. Therapy includes conventional therapy with diuretics and ...

Functionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic rats.

The occurrence of endothelial alterations in the liver and in the splanchnic vasculature of cirrhotic patients and experimental models of liver diseases has been demonstrated. However, the pathological role of the portal vein endothelium in this clinical context is scarcely studied and, therefore, deserves attention. In this context, we aimed to investigate whether pathological endothelial activation occurs in the portal vein of cirrhotic rats.

Exploration of interventional therapy strategy for portal vein occlusion: a case series study.

To explore the candidates, efficacy and safety of interventional therapies in the treatment of portal vein occlusion (PVO).

Microvascular proliferation of the portal vein branches in the liver of biliary atresia patients at Kasai operation is associated with a better long-term clinical outcome.

We previously showed an increased number of smaller portal vein (PV) branches in the portal areas of liver biopsy specimens of biliary atresia (BA) patients. We evaluated the correlation between this histopathological feature and the prognosis.

Intrahepatic arterial localizer guided transjugular intrahepatic portosystemic shunt placement: Feasibility, efficacy, and technical success assessed by a case series-a STROBE- compliant article.

Transjugular intra-hepatic portosystemic shunts (TIPS) had been considered a standard procedure in patients suffering from portal hypertension. The most challenging step in TIPS placement is blind puncture of the portal vein. We had established a localization method by introducing an Intra-Hepatic Arterial based puncture directing Localizer (IHAL) with the assistance of the enhanced computed tomography (CT) reconstruction. This study aimed to evaluate the feasibility, efficacy, and technical success of this...

Optimal head rotation angle for safe right internal jugular vein catheterization using out-of-plane approach: an ultrasonography study.

The most common complication following internal jugular vein catheterization is the puncture of the common carotidartery. We aimed to find an optimal head rotation angle for safe vein catheter insertion while minimizing the risk of arterypuncture.

Comment on "Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Versus Portal Vein Embolization for Hepatitis-related Hepatocellular Carcinoma. A Changing Paradigm in Modulation of Future Liver Remnant Before Major Hepatectomy" by A. Chan, et al: "Adapt the Means to the Objectives …Not the Other Way Round".

Prognostic role of the length of tumour-vein contact at the portal-superior mesenteric vein in patients having surgery for pancreatic cancer.

The length of tumour-vein contact between the portal-superior mesenteric vein (PV/SMV) and pancreatic head cancer, and its relationship to prognosis in patients undergoing pancreatic surgery, remains controversial.

Abnormalities of umbilical-portal circulation: from screening to diagnosis.

Abnormalities of umbilical-portal circulation are rare pathologies whose detection points in screening ultrasound are poorly taught. It can present as an unusual looking portal sinus, an abnormal trajectory of the umbilical vein, an anechoic intrahepatic image or more rarely as cardiomegaly. This can also be detected in the context of investigations of fetus with intrauterine growth retardation. Subsequently, the starting point of the diagnostic approach is based on the following dichotomy: does the umbilic...

Extensive thrombectomy as a legitimate strategy in living donor liver transplantation with advanced portal vein thrombosis.

Management of portal vein thrombosis (PVT), especially advanced PVT involving superior mesenteric vein (SMV), in living donor liver transplantation (LDLT) is challenging.

Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.

Portal vein thrombosis (PVT) is generally recognized as a prognostic factor in HCC. Our purpose is to assess and compare the survival of patients with PVT and without PVT, after Y-90 Trans-Arterial Radio-Embolization (TARE) of unresectable HCC, unresponsive to other loco-regional treatments.

Prevalence of prothrombotic factors in patients with Budd-Chiari syndrome or noncirrhotic nonmalignant portal vein thrombosis: A hospital-based observational study.

Background and Aims Comprehensive investigations on the prothrombotic factors of splanchnic vein thrombosis (SVT), including Budd-Chiari syndrome (BCS) and noncirrhotic nonmalignant portal vein thrombosis (PVT), in Eastern patients are scarce.

Anticoagulation in patients with cirrhosis and portal vein thrombosis: safety and beneficial effect on OLT free survival.

We read with interest the letter by Andrea Mancuso on clinical significance of portal vein thrombosis (PVT) in cirrhosis and potential utility of anticoagulation. In our prospective study, thrombocytopenia and previous decompensation of cirrhosis predicted PVT development in cirrhosis suggesting that severity of portal hypertension rather than liver failure plays a pathophysiologic role . This article is protected by copyright. All rights reserved.

Retrospective Comparative Study of Absolute Ethanol with N-Butyl-2-Cyanoacrylate in Percutaneous Portal Vein Embolization.

This study compared the efficacy of absolute ethanol with that of N-butyl-2-cyanoacrylate (NBCA) in portal vein embolization (PVE) before partial hepatectomy.


Quick Search